Recent News

• 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.06.2025 - ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
• 06.06.2025 - ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.04.2025 - Jefferies Global Healthcare Conference
• 05.28.2025 - ORIC-944 Program Update Call
• 05.28.2025 - ORIC-944 Program Update Call
• 05.28.2025 - ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients with mCRPC
• 05.28.2025 - ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data from Ongoing Phase 1b Trial of ORIC-944 in Combination with AR Inhibitors for the Treatment of Patients with mCRPC

Recent Filings

• 06.06.2025 - D Notice of Exempt Offering of Securities
• 06.06.2025 - 144 Report of proposed sale of securities
• 06.05.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 06.04.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.30.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.28.2025 - 8-K Current report
• 05.28.2025 - EX-99.1 EX-99.1